With the aim of deepening the knowledge of immune-based mechanisms that might influence tumor onset and relapse in ALK-positive ALCL patients, we assessed 14 genetic variants of 13 genes potentially involved in the anti-tumor immune response in 180 patients. This evidence concerns the gene ALK and anaplastic large cell lymphoma.